JW Pharmaceutical Corporation (KRX:001060)
South Korea · Delayed Price · Currency is KRW 21,250
+100 (0.47%)
At close: Oct 2, 2025
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 488.49 billion as of October 6, 2025. Its market cap has decreased by -24.94% in one year.
Market Cap
488.49B
Enterprise Value
506.69B
Revenue
742.85B
Ranking
n/a
PE Ratio
10.06
Stock Price
21,250.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 488.49B, an increase of 481.38%. That is a compound annual growth rate of 8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 488.49B | -13.03% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | 753.06B | 22.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |